DMD
Clinical trials for DMD explained in plain language.
Never miss a new study
Get alerted when new DMD trials appear
Sign up with your email to follow new studies for DMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to strengthen muscles in boys with devastating disease
Disease control Recruiting nowThis study is testing a new oral medicine called SAT-3247 for boys aged 7 to under 10 who have Duchenne Muscular Dystrophy (DMD) and can still walk. The main goals are to find a safe and well-tolerated dose and to see if the medicine can help improve muscle strength and function.…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for boys with DMD: weekly infusion aims to restore muscle protein
Disease control Recruiting nowThis study is testing a new drug called NS-089/NCNP-02 for boys with Duchenne muscular dystrophy (DMD) caused by a specific genetic error (exon 44). The drug is given as a weekly IV infusion and aims to help muscles produce more of a crucial protein called dystrophin. Researchers…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
One-Shot gene therapy tested in boys with devastating muscle disease
Disease control Recruiting nowThis early-stage study is testing a new, one-time gene therapy called BBM-D101 for boys with Duchenne Muscular Dystrophy (DMD). The main goal is to see if the treatment is safe and well-tolerated. Researchers will also check if it helps improve muscle strength and function over a…
Matched conditions: DMD
Phase: PHASE1, PHASE2 • Sponsor: Belief BioMed (Beijing) Co., Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Swiss database tracks rare muscle diseases to speed up new treatments
Knowledge-focused Recruiting nowThis project is a national registry in Switzerland that collects health information from people with rare neuromuscular diseases like Duchenne muscular dystrophy and spinal muscular atrophy. It aims to connect patients to new treatment trials, help researchers understand these di…
Matched conditions: DMD
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC